Anika Therapeutics, Inc. (ANIK)
21.57
+0.46
(+2.18%)
USD |
NASDAQ |
Sep 02, 16:00
21.57
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics Cash and Short Term Investments (Quarterly) : 38.41M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 38.41M |
| March 31, 2026 | 41.02M |
| December 31, 2025 | 57.48M |
| September 30, 2025 | 57.99M |
| June 30, 2025 | 53.17M |
| March 31, 2025 | 53.37M |
| December 31, 2024 | 55.63M |
| September 30, 2024 | 62.37M |
| June 30, 2024 | 62.82M |
| March 31, 2024 | 68.63M |
| December 31, 2023 | 68.74M |
| September 30, 2023 | 70.65M |
| June 30, 2023 | 65.07M |
| March 31, 2023 | 79.74M |
| December 31, 2022 | 86.33M |
| September 30, 2022 | 87.78M |
| June 30, 2022 | 91.39M |
| March 31, 2022 | 90.32M |
| December 31, 2021 | 94.39M |
| September 30, 2021 | 90.98M |
| June 30, 2021 | 97.18M |
| March 31, 2021 | 94.60M |
| December 31, 2020 | 98.32M |
| September 30, 2020 | 124.76M |
| June 30, 2020 | 144.37M |
| Date | Value |
|---|---|
| March 31, 2020 | 92.28M |
| December 31, 2019 | 184.94M |
| September 30, 2019 | 173.21M |
| June 30, 2019 | 141.45M |
| March 31, 2019 | 166.74M |
| December 31, 2018 | 159.01M |
| September 30, 2018 | 149.01M |
| June 30, 2018 | 139.30M |
| March 31, 2018 | 163.05M |
| December 31, 2017 | 157.26M |
| September 30, 2017 | 152.71M |
| June 30, 2017 | 142.87M |
| March 31, 2017 | 138.62M |
| December 31, 2016 | 124.76M |
| September 30, 2016 | 120.30M |
| June 30, 2016 | 111.62M |
| March 31, 2016 | 115.84M |
| December 31, 2015 | 138.46M |
| September 30, 2015 | 130.48M |
| June 30, 2015 | 122.43M |
| March 31, 2015 | 112.30M |
| December 31, 2014 | 106.91M |
| September 30, 2014 | 91.77M |
| June 30, 2014 | 84.88M |
| March 31, 2014 | 82.16M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 236.88M |
| MiMedx Group, Inc. | 135.84M |
| ABVC BioPharma, Inc. | 0.0944M |
| Enovis Corp. | 12.56M |
| Edwards Lifesciences Corp. | 4.255B |